Related references
Note: Only part of the references are listed.Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
Darin K. Edwards et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl et al.
MOLECULAR THERAPY (2017)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi et al.
NATURE (2017)
The 'anti-hype' vaccine
Laura DeFrancesco
NATURE BIOTECHNOLOGY (2017)
Type I lnterferons Modulate CD8+ T Cell Immunity to mRNA Vaccines
Ans De Beuckelaer et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection (vol 168, pg 1114, 2017)
Justin M. Richner et al.
CELL (2017)
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
Michela Brazzoli et al.
JOURNAL OF VIROLOGY (2016)
Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
Sandra Van Lint et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy
Susanne M. Rittig et al.
ONCOIMMUNOLOGY (2016)
Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
Abderraouf Selmi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Recent innovations in mRNA vaccines
Jeffrey B. Ulmer et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
Ans De Beuckelaer et al.
MOLECULAR THERAPY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
Diletta Magini et al.
PLOS ONE (2016)
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
Aleksandra Kowalczyk et al.
VACCINE (2016)
Alphavirus Infection: Host Cell Shut-Off and Inhibition of Antiviral Responses
Jelke J. Fros et al.
VIRUSES-BASEL (2016)
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
Margit Schnee et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon
Katrijn Broos et al.
Molecular Therapy-Nucleic Acids (2016)
Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
Hyewon Youn et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes
Sandra Lazzaro et al.
IMMUNOLOGY (2015)
A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile
Regina Heidenreich et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates
Oleg V. Pyankov et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Control of adaptive immunity by the innate immune system
Akiko Iwasaki et al.
NATURE IMMUNOLOGY (2015)
Control of alphavirus-based gene expression using engineered riboswitches
Christie L. Bell et al.
VIROLOGY (2015)
The 5′ and 3′ ends of alphavirus RNAs - Non-coding is not non-functional
Jennifer L. Hyde et al.
VIRUS RESEARCH (2015)
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
Hubert Kuebler et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Intralymphatic immunotherapy
Gabriela Senti et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2015)
The ReNAissanCe of mRNA-based cancer therapy
Sandra Van Lint et al.
EXPERT REVIEW OF VACCINES (2015)
Self-replicating alphavirus RNA vaccines
Karl Ljungberg et al.
EXPERT REVIEW OF VACCINES (2015)
Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
Willy M. Bogers et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
Martin Sebastian et al.
BMC CANCER (2014)
Kinetic and Phenotypic Analysis of CD8+ T Cell Responses after Priming with Alphavirus Replicons and Homologous or Heterologous Booster Immunizations
Maria Lisa Knudsen et al.
JOURNAL OF VIROLOGY (2014)
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
Luis A. Brito et al.
MOLECULAR THERAPY (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
Staufen1 senses overall transcript secondary structure to regulate translation
Emiliano P. Ricci et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
A Viral RNA Structural Element Alters Host Recognition of Nonself RNA
Jennifer L. Hyde et al.
SCIENCE (2014)
Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice
Yingxia Wen et al.
VACCINE (2014)
Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles
Kenneth C. McCullough et al.
VACCINES (2014)
Post-transcriptional regulation of gene expression in innate immunity
Susan Carpenter et al.
NATURE REVIEWS IMMUNOLOGY (2014)
TLR signaling in B-cell development and activation
Zhaolin Hua et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Regulation and dysregulation of 3′UTR-mediated translational control
Jie Jia et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Potential therapeutic applications of RNA cap analogs
Marcin Ziemniak et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
Charlotte Pollard et al.
MOLECULAR THERAPY (2013)
Challenges and advances towards the rational design of mRNA vaccines
Charlotte Pollard et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity
Giulietta Maruggi et al.
VIROLOGY (2013)
mRNA From a chemical blueprint for protein production to an off-the-shelf therapeutic
Sandra Van Lint et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A novel, disruptive vaccination technology Self-adjuvanted RNActive® vaccines
Karl-Josef Kallen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Cationic lipids activate intracellular signaling pathways
Caroline Lonez et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Engineering Nano- and Microparticles to Tune Immunity
James J. Moon et al.
ADVANCED MATERIALS (2012)
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect
Mariola Fotin-Mleczek et al.
JOURNAL OF GENE MEDICINE (2012)
Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
Rosemary L. Kanasty et al.
MOLECULAR THERAPY (2012)
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
Benjamin Petsch et al.
NATURE BIOTECHNOLOGY (2012)
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Developing mRNA-vaccine technologies
Thomas Schlake et al.
RNA BIOLOGY (2012)
Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
M. Diken et al.
GENE THERAPY (2011)
A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding
Carlo Iavarone et al.
JOURNAL OF IMMUNOLOGY (2011)
ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8+ T Cells
Peter Duewell et al.
JOURNAL OF IMMUNOLOGY (2011)
Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
Mariola Fotin-Mleczek et al.
JOURNAL OF IMMUNOTHERAPY (2011)
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Xingfang Su et al.
MOLECULAR PHARMACEUTICS (2011)
Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
Susanne M. Rittig et al.
MOLECULAR THERAPY (2011)
Protein expression from exogenous mRNA Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway
Christina Lorenz et al.
RNA BIOLOGY (2011)
Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
Sebastian Kreiter et al.
CANCER RESEARCH (2010)
Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo
A. N. Kuhn et al.
GENE THERAPY (2010)
Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity
Francesca Avogadri et al.
PLOS ONE (2010)
Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein
Catherine C. Cruz et al.
VIROLOGY (2010)
Toll-like receptors - sentries in the B-cell response
Isabelle Bekeredjian-Ding et al.
IMMUNOLOGY (2009)
Intralymphatic Injections as a New Administration Route for Allergen-Specific Immunotherapy
Julia M. Martinez-Gomez et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2009)
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Venezuelan Equine Encephalitis Virus Disrupts STAT1 Signaling by Distinct Mechanisms Independent of Host Shutoff
Jason D. Simmons et al.
JOURNAL OF VIROLOGY (2009)
Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy
Sergey S. Seregin et al.
MOLECULAR THERAPY (2009)
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells
Sammy Bedoui et al.
NATURE IMMUNOLOGY (2009)
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
David I. Bernstein et al.
VACCINE (2009)
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
Benjamin Weide et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA
Aude Bonehill et al.
MOLECULAR THERAPY (2008)
Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
Katalin Kariko et al.
MOLECULAR THERAPY (2008)
Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
Gabriela Senti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Duration of antigen expression in vivo following DNA immunization modifies the magnitude, contraction, and secondary responses of CD8+ T lymphocytes
Avi-Hai Hovav et al.
JOURNAL OF IMMUNOLOGY (2007)
Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent
J. Probst et al.
GENE THERAPY (2007)
A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication
Sun Suk Kim et al.
GASTROENTEROLOGY (2007)
mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes
M. Mockey et al.
CANCER GENE THERAPY (2007)
Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection
Kathleen C. F. Sheehan et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA
Birgit Scheel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA
K Karikó et al.
IMMUNITY (2005)
Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN
KPJM van Gisbergen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Deviation from major codons in the Toll-like receptor genes is associated with low Toll-like receptor expression
F Zhong et al.
IMMUNOLOGY (2005)
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
SS Diebold et al.
SCIENCE (2004)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Immunostimulating capacities of stabilized RNA molecules
B Scheel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli
M Jefford et al.
BLOOD (2003)
A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea
S Ishimoto et al.
AUDIOLOGY AND NEURO-OTOLOGY (2003)
Ribosomal binding to the internal ribosomal entry site of classical swine fever virus
VG Kolupaeva et al.
RNA (2000)
Uses of granulocyte-macrophage colony-stimulating factor in vaccine development
TL Warren et al.
CURRENT OPINION IN HEMATOLOGY (2000)
Share Paper
